COMMUNIQUÉS West-GlobeNewswire

Cutera, Inc. to Announce Fourth Quarter and Full-Year 2018 Results
30/01/2019
BRISBANE, Calif., Jan. 30, 2019 (GLOBE NEWSWIRE) -- Cutera, Inc. (Nasdaq: CUTR ) (“Cutera” or the “Company”), a leading provider of laser and energy-based aesthetic systems for practitioners worldwide, will announce [...]
Assure Holdings Continues Expansion with New Partnership in Louisiana
30/01/2019
New Partnership Brings Two Additional Surgeons to Assure’s Platform DENVER, Jan. 30, 2019 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “ Company ” or “ Assure ”) (TSXV: IOM; OTCPK: ARHH), a provider of intraoperative [...]
Kane Biotech Expands Previously-Announced Single Largest Order of bluestem™ Products
30/01/2019
Major Retailer Orders Additional Inventory in Anticipation of High Demand WINNIPEG, Manitoba, Jan. 30, 2019 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE, OTCQB:KNBIF), (the “Corporation” or “Kane Biotech”), is [...]
IntelGenx Facility Undergoes U.S. FDA Pre-Approval Inspection Related to RIZAPORT® NDA
30/01/2019
SAINT LAURENT, Quebec, Jan. 30, 2019 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) (“IntelGenx”), a leading oral drug delivery company, today announced that the U.S. Food and Drug Administration (“FDA”) [...]
Neos Therapeutics Announces Appointment of James Robinson to Board of Directors
30/01/2019
DALLAS and FORT WORTH, Texas, Jan. 30, 2019 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq: NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative extended-release (XR) [...]
AMAG Pharmaceuticals to Host Fourth Quarter and Full Year 2018 Financial Results Conference Call and Webcast on Thursday, February 7, 2019 at 8:00 a.m. ET
30/01/2019
WALTHAM, Mass., Jan. 30, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that its fourth quarter and full year 2018 financial results will be released on Thursday, February 7, 2019 [...]
CytomX Therapeutics to Host Research and Development Day on February 26, 2019
30/01/2019
SOUTH SAN FRANCISCO, Calif., Jan. 30, 2019 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a clinical-stage oncology-focused biopharmaceutical company pioneering a novel class of investigational antibody [...]
BioTime Inc. Affiliate Company OncoCyte Corporation Reports Successful Results With DetermaVu™ Diagnostic Test for Lung Cancer
30/01/2019
ALAMEDA, Calif., Jan. 30, 2019 (GLOBE NEWSWIRE) -- BioTime, Inc. (NYSE American: BTX), a clinical-stage biotechnology company focused on degenerative diseases, today announced that its affiliate company, OncoCyte [...]
Aduro Biotech Announces Strategic Reset
30/01/2019
BERKELEY, Calif., Jan. 30, 2019 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ: ADRO) today announced a strategic reset to focus on Aduro’s core strengths – discovery and development of novel product candidates in the [...]
Le Dr. Eric Simpson présentera les résultats obtenus avec bermekimab dans le traitement de la dermatite atopique lors de l’Assemblée annuelle 2019 de l’American Academy of Dermatology (AAD)
30/01/2019
Bermekimab assure un traitement rapide de la dermatite atopique, parallèlement à une diminution des démangeaisons et de la douleur AUSTIN, Texas, 30 janv. 2019 (GLOBE NEWSWIRE) -- XBiotech (NASDAQ : XBIT) a annoncé [...]
TG Therapeutics, Inc. Announces Publication of Clinical Data from the Phase I Triple Therapy Combination Trial of Ublituximab, Umbralisib, and Ibrutinib in The Lancet Haematology
30/01/2019
NEW YORK, Jan. 30, 2019 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced the publication of results from the multicenter Phase 1 triple combination trial of ublituximab (TG-1101), the Company’s [...]
Stemline Therapeutics Announces Validation of Marketing Authorization Application (MAA) by the European Medicines Agency (EMA)
30/01/2019
NEW YORK, Jan. 30, 2019 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq: STML), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel oncology therapeutics, today [...]
Aino Health AB (publ): Aino Health signs partnership agreement with Uudenmaan Työterveys, (Nylands Arbetshälsa)
30/01/2019
30 January 2019 Aino Health and Uudenmaan Työterveys, (Nylands Arbetshälsa), have signed a partnership agreement regarding Aino's SaaS solution HealthManager and Aino's consulting services in preventive healthcare. The [...]
Kamada Appoints Senior Biopharmaceutical Executive Michal Ayalon, Ph.D., as Vice President of Research and Development
30/01/2019
REHOVOT, Israel, Jan. 30, 2019 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ & TASE: KMDA), a plasma-derived protein therapeutics company, announced today the appointment of Michal Ayalon, Ph.D., as Vice President of [...]
Mithra Announces Positive Top-line Results of Estelle® Phase III Oral Contraceptive Study in U.S/Canada
30/01/2019
Mithra Announces Positive Top-line Results of Estelle ® Phase III Oral Contraceptive Study in U.S/Canada Primary efficacy endpoint indicates excellent contraceptive efficacy, with a Pearl Index (PI) of 2.41 1 per 100 [...]
Emerald Health Therapeutics Announces Discharge of Litigation
30/01/2019
VANCOUVER, British Columbia, Jan. 30, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV:EMH; OTCQX:EMHTF) announced today that its wholly-owned subsidiary, Verdélite Sciences Inc. (“Verdélite [...]
Eyenovia Announces Positive Results in the MicroStat MIST-1 Phase III Registration Study for Mydriasis
30/01/2019
MIST-1 study met primary endpoint First-in-class fixed combination mydriatic agent demonstrated robust efficacy, high tolerability; Study further validates OpteJet™ platform delivery technology Company to host [...]
Trevena Announces $10 Million Registered Direct Offering of Common Stock
30/01/2019
CHESTERBROOK, Pa., Jan. 30, 2019 (GLOBE NEWSWIRE) -- Trevena, Inc. (Nasdaq: TRVN) (the “Company”) today announced that it entered into securities purchase agreements with two healthcare-focused institutional investors, [...]
Axsome Therapeutics Initiates Phase 2 Trial of AXS-12 in Narcolepsy
30/01/2019
Topline results anticipated in 2Q 2019 NEW YORK, Jan. 30, 2019 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a clinical-stage biopharmaceutical company developing novel therapies for the management of [...]

Pages